Medical Small Cap Moving Forward with Cutting-Edge Technological Innovations

  ()
Premier Health is methodically building an innovative telemedicine platform in Canada, is purchasing a venerable telemedicine firm, and sees 2020 as the year of execution. read more >

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data

  ()
Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. read more >

Plus Therapeutics Shares Trade Higher on Q3 Earnings and Business Restructuring

  ()
Plus Therapeutics shares traded higher after the firm reported Q3/19 financial and business results. In the most recent quarter, the company completed the change of its name, relocated its headquarters to Austin, and raised $15 million for R&D and working capital. read more >

Sales of Antibiotic Alternative for Livestock Feed Accelerate in Asia

  ()
With antibiotic resistance a major health issue, the search is on for effective alternatives to replace antibiotics in livestock feed to promote growth. read more >

Exicure's Collaboration with Allergan on Treating Hair Loss Disorders Sends Shares Higher

  ()
Shares of Exicure Inc. opened 30% higher after the firm reported that it entered into a collaboration agreement with Allergan to discover and develop SNA-based treatments for hair loss disorders. The terms of the deal provide for a $25 million upfront payment to Exicure with the potential to grow to $750 million. read more >

Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes

Contributed Opinion
  ()
A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. read more >

Seachange in Mexico on Cannabis Could Benefit This Small Cap

Contributed Opinion
  ()
Technical analyst Clive Maund highlights a small-cap that may be poised to benefit from the recent Mexican Supreme Court decision on cannabis. read more >

Electromed Earnings Spark a 25% Increase in Its Share Price

  ()
Shares of SmartVest maker Electromed traded 25% higher after the firm reported Q1/20 earnings. The firm's shares set a 52-week high price after reporting a 14.1% increase in year-over-year quarterly revenue and a six-fold increase in net income per share. read more >
News Update

Biopharma Presents Data on Alcoholic Hepatitis Therapeutic at Liver Meeting

News Update
  ()
The company intends to follow up in 2020 with a Phase 2b clinical trial. read more >

FDA Approval of Peanut Allergy Treatment Expected Next Year

Research Report
  ()
The current status, catalysts and outlook for the immunotherapy are discussed in a ROTH Capital Partners report. read more >

Expert Investing Ideas

"DRRX earned a $10M milestone payment from Gilead."

–Ed Arce, H.C. Wainwright & Co.


"The market for DRRX's POSIMIR could be substantial."

–Brian Marckx, Zacks Small-Cap Research


Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical
News Update

Clinical Trial Results for Alcoholic Hepatitis Drug Delivered in Webcast

News Update
  ()
The online presentation coincides with The Liver Meeting 2019, at which data also are shared. read more >

Castle Biosciences Shares Storm Higher After Quadrupling Q3 YoY Revenue

  ()
Shares of melanoma and other skin cancers diagnostic firm Castle Biosciences Inc. traded more than 15% higher after the firm announced Q3/19 financial and operational results. read more >

Imagin Medical Poised for Breakout with Bladder Cancer Detection Device in FDA Approval Process

Contributed Opinion
  ()
A new advancement in bladder-related endoscopic surgery is endorsed and de-risked. read more >

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

  ()
Shares of Iovance Biotherapeutics traded 12% higher after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. read more >